RxDoctor Payments Data

Melissa Bruhn, MD

Obstetrics · Thomasville, GANPI 1598710402

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Astellas Pharma US Inc at 31.9% of the total.

$1,212in general payments, 2019–2025

Across 50 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$386
  • Hologic Sales And Service, LLC$262
  • Sumitomo Pharma America, Inc.$183
  • AbbVie$171
  • Pfizer$49
  • Millicent US Inc$43
  • plus $117 from 5 others

What the payments were for

  • Food & beverage$1,15295%
  • Education$605%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc21$386
Hologic Sales And Service, LLC8$262
Sumitomo Pharma America, Inc.4$183
AbbVie6$171
Pfizer3$49
Millicent US Inc2$43
Bayer2$38
Organon1$22
Optumhealth Care Solutions, LLC1$20
Masimo Corporation1$20
Amgen1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,212 in reported general payments places this provider in the 55th percentile of 41 obstetrics providers in Georgia.

See all obstetrics providers in Georgia

Medicare billing

Part B allowed, 2024
$34,767
Medicare patients
169
Services billed
576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremproEstrogen,con/M-Progest Acet19$7,345
PremarinEstrogens, Conjugated17$4,149
Estradiol80$3,301
Estradiol (Twice Weekly)Estradiol15$1,389
ValacyclovirValacyclovir Hcl11$499
Venlafaxine Hcl ErVenlafaxine Hcl14$300
Triamcinolone Acetonide12$105
Escitalopram Oxalate15$99
Acyclovir13$42

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPrempro, Premarin$49$11,49436 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 41 obstetrics providers in Georgia.

Other obstetrics in Thomasville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →